Results 201 to 210 of about 220,523 (312)

Spindle Cell Lesions of the Breast: A 12‐Year Experience

open access: yesANZ Journal of Surgery, EarlyView.
This 12‐year, single‐centre study examined 30 core‐biopsy‐diagnosed breast spindle cell lesions (BrSCL), classified as atypical (ASCL, n = 10) or bland (BSCL, n = 20). Following excision, 80% of ASCLs proved malignant, comprising sarcoma, malignant phyllodes tumour and metaplastic carcinoma.
Shalvin Jassal   +4 more
wiley   +1 more source

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies

open access: yesBritish Journal of Haematology, EarlyView.
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi   +3 more
wiley   +1 more source

Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Preclinical and clinical studies suggest that selective serotonin reuptake inhibitors (SSRIs) can stimulate haematopoiesis by promoting proliferation and mobilization of haematopoietic stem and progenitor cells, but whether SSRI use influences myeloid malignancy risk remains unclear.
Katrine Mose   +5 more
wiley   +1 more source

Transcriptional landscape of direct reprogramming toward the hematopoietic lineage. [PDF]

open access: yesiScience
Cwycyshyn J   +7 more
europepmc   +1 more source

Acute Monoblastic Leukemia Presenting with Multiple Granulocytic Sarcoma Nodules

open access: yesTurkish Journal of Hematology, 2017
Asude Kara   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy